240 related articles for article (PubMed ID: 17513597)
1. Cryptococcus neoformans biofilm formation depends on surface support and carbon source and reduces fungal cell susceptibility to heat, cold, and UV light.
Martinez LR; Casadevall A
Appl Environ Microbiol; 2007 Jul; 73(14):4592-601. PubMed ID: 17513597
[TBL] [Abstract][Full Text] [Related]
2. Biofilm formation by Fusarium oxysporum f. sp. cucumerinum and susceptibility to environmental stress.
Peiqian L; Xiaoming P; Huifang S; Jingxin Z; Ning H; Birun L
FEMS Microbiol Lett; 2014 Jan; 350(2):138-45. PubMed ID: 24164057
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro.
Martinez LR; Casadevall A
Antimicrob Agents Chemother; 2006 Mar; 50(3):1021-33. PubMed ID: 16495265
[TBL] [Abstract][Full Text] [Related]
4. Temperature affects the susceptibility of Cryptococcus neoformans biofilms to antifungal agents.
Pettit RK; Repp KK; Hazen KC
Med Mycol; 2010 Mar; 48(2):421-6. PubMed ID: 19637092
[TBL] [Abstract][Full Text] [Related]
5. Cryptococcus neoformans cells in biofilms are less susceptible than planktonic cells to antimicrobial molecules produced by the innate immune system.
Martinez LR; Casadevall A
Infect Immun; 2006 Nov; 74(11):6118-23. PubMed ID: 17057089
[TBL] [Abstract][Full Text] [Related]
6. The use of chitosan to damage Cryptococcus neoformans biofilms.
Martinez LR; Mihu MR; Han G; Frases S; Cordero RJ; Casadevall A; Friedman AJ; Friedman JM; Nosanchuk JD
Biomaterials; 2010 Feb; 31(4):669-79. PubMed ID: 19819009
[TBL] [Abstract][Full Text] [Related]
7. Characterization of phenotypic switching in Cryptococcus neoformans biofilms.
Martinez LR; Ibom DC; Casadevall A; Fries BC
Mycopathologia; 2008 Oct; 166(4):175-80. PubMed ID: 18568421
[TBL] [Abstract][Full Text] [Related]
8. Specific antibody can prevent fungal biofilm formation and this effect correlates with protective efficacy.
Martinez LR; Casadevall A
Infect Immun; 2005 Oct; 73(10):6350-62. PubMed ID: 16177306
[TBL] [Abstract][Full Text] [Related]
9. In vitro Antifungal Activity of a Novel Antimicrobial Peptide AMP-17 Against Planktonic Cells and Biofilms of
Yang L; Tian Z; Zhou L; Zhu L; Sun C; Huang M; Peng J; Guo G
Infect Drug Resist; 2022; 15():233-248. PubMed ID: 35115792
[TBL] [Abstract][Full Text] [Related]
10. Reduced phagocytosis and killing of Cryptococcus neoformans biofilm-derived cells by J774.16 macrophages is associated with fungal capsular production and surface modification.
Lee HH; Del Pozzo J; Salamanca SA; Hernandez H; Martinez LR
Fungal Genet Biol; 2019 Nov; 132():103258. PubMed ID: 31356873
[TBL] [Abstract][Full Text] [Related]
11. EDTA inhibits biofilm formation, extracellular vesicular secretion, and shedding of the capsular polysaccharide glucuronoxylomannan by Cryptococcus neoformans.
Robertson EJ; Wolf JM; Casadevall A
Appl Environ Microbiol; 2012 Nov; 78(22):7977-84. PubMed ID: 22941091
[TBL] [Abstract][Full Text] [Related]
12. Antibody-mediated immobilization of Cryptococcus neoformans promotes biofilm formation.
Robertson EJ; Casadevall A
Appl Environ Microbiol; 2009 Apr; 75(8):2528-33. PubMed ID: 19251903
[TBL] [Abstract][Full Text] [Related]
13. Candida albicans survival and biofilm formation under starvation conditions.
Ning Y; Hu X; Ling J; Du Y; Liu J; Liu H; Peng Z
Int Endod J; 2013 Jan; 46(1):62-70. PubMed ID: 22757642
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of biofilm formation by Candida albicans.
Ramage G; Vandewalle K; Wickes BL; López-Ribot JL
Rev Iberoam Micol; 2001 Dec; 18(4):163-70. PubMed ID: 15496122
[TBL] [Abstract][Full Text] [Related]
15. Specific antibody to Cryptococcus neoformans glucurunoxylomannan antagonizes antifungal drug action against cryptococcal biofilms in vitro.
Martinez LR; Christaki E; Casadevall A
J Infect Dis; 2006 Jul; 194(2):261-6. PubMed ID: 16779734
[TBL] [Abstract][Full Text] [Related]
16. Use of a stainless steel washer platform to study Acinetobacter baumannii adhesion and biofilm formation on abiotic surfaces.
Orsinger-Jacobsen SJ; Patel SS; Vellozzi EM; Gialanella P; Nimrichter L; Miranda K; Martinez LR
Microbiology (Reading); 2013 Dec; 159(Pt 12):2594-2604. PubMed ID: 24025603
[TBL] [Abstract][Full Text] [Related]
17. Improvement of XTT assay performance for studies involving Candida albicans biofilms.
da Silva WJ; Seneviratne J; Parahitiyawa N; Rosa EA; Samaranayake LP; Del Bel Cury AA
Braz Dent J; 2008; 19(4):364-9. PubMed ID: 19180329
[TBL] [Abstract][Full Text] [Related]
18. Biofilm formation by Cryptococcus neoformans under distinct environmental conditions.
Ravi S; Pierce C; Witt C; Wormley FL
Mycopathologia; 2009 Jun; 167(6):307-14. PubMed ID: 19130292
[TBL] [Abstract][Full Text] [Related]
19. Comparison of three assays for the quantification of Candida biomass in suspension and CDC reactor grown biofilms.
Honraet K; Goetghebeur E; Nelis HJ
J Microbiol Methods; 2005 Dec; 63(3):287-95. PubMed ID: 15936097
[TBL] [Abstract][Full Text] [Related]
20. Adhesion of Histoplasma capsulatum to pneumocytes and biofilm formation on an abiotic surface.
Pitangui NS; Sardi JC; Silva JF; Benaducci T; Moraes da Silva RA; Rodríguez-Arellanes G; Taylor ML; Mendes-Giannini MJ; Fusco-Almeida AM
Biofouling; 2012; 28(7):711-8. PubMed ID: 22784100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
